Skip to content

Kidney Tumor Study Klinikum Region Hannover

Kidney Tumor Study Klinikum Region Hannover - NTS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00031089
Enrollment
1000
Registered
2023-01-20
Start date
2021-05-19
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C64

Interventions

Group 1: all patient, which are operated on renal cell cancer in the urologic departments of the KRH GmbH

Sponsors

Abteilung für Urologie am KRH Klinikum Siloah
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - histopathologic proof of renal cell cancer - existing of mri/ct-scan imaging - surgery at urologic department of Klinikum Region Hannover - consent of partipitation for the study

Exclusion criteria

Exclusion criteria: - hereditary or aquired bleeding tendency - anatomic anomaly which prevent standard approach

Design outcomes

Primary

MeasureTime frame
The primary outcome is to analyse the rate of compilcations (= Grad III nach Clavien-Dindo) after surgery on renal cell cancer depending on the operative method and R.E.N.A.L.-Score.

Secondary

MeasureTime frame
Secundary outcome is to analyse the impact of the operative method an R.E.N.A.L.-Score on the intraoperative factors and blood loose, warm ischemia, and operative time and the perioperative parameters, level of hemoglobin, glomerulare filtrationsrate, necessity of drain and duration of stay of drain. Furthemore it is analysed, if it is an training operation or expert operation (more than 40 Operation in the last three years).

Countries

Germany

Contacts

Public ContactLina El-Malazi

Abteilung für Urologie am KRH Klinikum Siloah

urologie.siloah@krh.de+49 511 927 3200

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026